See more : Chamni’s Eye Public Company Limited (CEYE.BK) Income Statement Analysis – Financial Results
Complete financial analysis of Trees Corporation (CANN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Trees Corporation, a leading company in the Drug Manufacturers – Specialty & Generic industry within the Healthcare sector.
- CZR Resources Ltd (CZR.AX) Income Statement Analysis – Financial Results
- Norinco International Cooperation Ltd. (000065.SZ) Income Statement Analysis – Financial Results
- Seri Industrial S.p.A. (SERI.MI) Income Statement Analysis – Financial Results
- Allegion plc (ALLE) Income Statement Analysis – Financial Results
- Dexxos Participações S.A. (DEXP3.SA) Income Statement Analysis – Financial Results
Trees Corporation (CANN)
Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Website: https://www.treescann.com
About Trees Corporation
Trees Corporation provides products and services to the regulated cannabis industry and non-cannabis customers in the United States. The company operates through Retail and Cultivation segments. It operates a licensed 17,000 square foot light deprivation greenhouse cultivation facility; and a retail dispensary store in Englewood, Colorado, as well as two retail stores in Portland, Oregon. The company was formerly known as General Cannabis Corp. and changed its name to Trees Corporation in June 2022. Trees Corporation was incorporated in 2013 and is headquartered in Denver, Colorado.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 18.14M | 13.44M | 5.93M | 7.12M | 3.67M | 4.62M | 3.52M | 2.98M | 1.76M | 240.21K | 0.00 | 21.03K | 61.56K | 100.64K | 38.00K |
Cost of Revenue | 11.56M | 8.58M | 4.44M | 5.47M | 2.47M | 3.74M | 2.79M | 1.99M | 1.42M | 68.54K | 186.15K | 48.11K | 31.25K | 28.19K | 7.44K |
Gross Profit | 6.57M | 4.87M | 1.49M | 1.65M | 1.20M | 879.76K | 736.37K | 988.48K | 339.95K | 171.67K | -186.15K | -27.08K | 30.31K | 72.45K | 30.57K |
Gross Profit Ratio | 36.24% | 36.20% | 25.10% | 23.21% | 32.71% | 19.05% | 20.91% | 33.15% | 19.28% | 71.47% | 0.00% | -128.75% | 49.24% | 71.99% | 80.43% |
Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
General & Administrative | 1.38M | 7.71M | 4.00M | 7.50M | 9.95M | 12.14M | 7.44M | 6.31M | 7.30M | 2.64M | 776.00K | 40.72K | 51.47K | 18.34K | 63.31K |
Selling & Marketing | 8.29M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 9.67M | 7.71M | 4.00M | 7.50M | 9.95M | 12.14M | 7.44M | 6.31M | 7.30M | 2.64M | 776.00K | 40.72K | 51.47K | 18.34K | 63.31K |
Other Expenses | 874.41K | 331.38K | 500.57K | 215.46K | 115.70K | 149.50K | 125.91K | 394.22K | 282.83K | 66.26K | 0.00 | -59.25K | 38.96K | 0.00 | 0.00 |
Operating Expenses | 10.55M | 8.04M | 4.50M | 7.72M | 10.06M | 12.29M | 7.56M | 6.70M | 7.58M | 2.71M | 1.03M | -18.53K | 90.43K | 18.34K | 63.31K |
Cost & Expenses | 22.11M | 16.62M | 8.94M | 13.19M | 12.53M | 16.03M | 10.35M | 8.69M | 9.01M | 2.78M | 1.22M | 29.58K | 121.67K | 46.54K | 70.75K |
Interest Income | 0.00 | 234.38K | 1.31M | 748.78K | 2.37M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 18.00 | 110.00 | 22.00 | 89.00 |
Interest Expense | 2.58M | 2.80M | 1.31M | 748.78K | 2.37M | 4.56M | 1.37M | 6.29M | 1.75M | 1.00M | 0.00 | 18.00 | 110.00 | 22.00 | 89.00 |
Depreciation & Amortization | 2.68M | 1.60M | 991.20K | 485.91K | 115.70K | 62.44K | 125.91K | 394.22K | 282.83K | 66.26K | 962.15K | 23.58K | -1.32K | 107.07K | -250.00 |
EBITDA | -1.64M | -5.37M | -6.12M | -6.19M | -11.33M | -11.51M | -6.73M | -8.83M | -6.96M | -5.86M | 0.00 | -8.55K | -61.43K | 570.00 | -32.74K |
EBITDA Ratio | -9.03% | -21.21% | -39.98% | -80.76% | -236.35% | -247.68% | -190.22% | -178.35% | -394.82% | -1,028.07% | 0.00% | 15.40% | -99.78% | 106.96% | -86.82% |
Operating Income | -3.97M | -3.17M | -3.01M | -6.07M | -8.86M | -11.41M | -7.05M | -7.06M | -7.24M | -2.54M | -962.15K | -20.34K | -60.11K | 570.00 | -32.74K |
Operating Income Ratio | -21.91% | -23.61% | -50.83% | -85.19% | -241.70% | -246.97% | -200.09% | -236.65% | -410.86% | -1,055.65% | 0.00% | -96.72% | -97.64% | 0.57% | -86.16% |
Total Other Income/Expenses | -2.92M | -6.10M | -5.41M | -1.55M | -4.95M | -5.56M | -1.17M | -3.11M | -1.54M | -4.39M | -260.00K | 18.00 | 1.43K | 22.00 | 339.00 |
Income Before Tax | -6.89M | -9.28M | -8.43M | -7.62M | -10.79M | -16.97M | -8.22M | -32.80M | -8.79M | -6.93M | -1.22M | -20.32K | -58.68K | 592.00 | -32.41K |
Income Before Tax Ratio | -38.01% | -68.99% | -142.18% | -107.01% | -294.22% | -367.50% | -233.41% | -1,099.93% | -498.38% | -2,885.08% | 0.00% | -96.63% | -95.32% | 0.59% | -85.27% |
Income Tax Expense | 187.85K | 204.92K | 1.89M | 907.60K | 4.04M | -1.01M | 1.37M | 6.29M | 1.75M | 1.00M | -260.00K | -11.81K | -110.00 | 1.32K | -89.00 |
Net Income | -7.08M | -9.48M | -10.31M | -8.53M | -14.83M | -16.97M | -8.22M | -32.80M | -8.79M | -6.93M | -1.22M | -20.32K | -58.68K | -726.00 | -32.41K |
Net Income Ratio | -39.05% | -70.52% | -173.99% | -119.75% | -404.43% | -367.50% | -233.41% | -1,099.93% | -498.38% | -2,885.08% | 0.00% | -96.63% | -95.32% | -0.72% | -85.27% |
EPS | -0.06 | -0.07 | -0.15 | -0.17 | -0.39 | -0.49 | -0.40 | -2.12 | -0.63 | -0.51 | -0.09 | 0.00 | -0.01 | 0.00 | 0.00 |
EPS Diluted | -0.06 | -0.07 | -0.15 | -0.17 | -0.39 | -0.49 | -0.40 | -2.12 | -0.63 | -0.51 | -0.09 | 0.00 | -0.01 | 0.00 | 0.00 |
Weighted Avg Shares Out | 117.20M | 138.96M | 69.54M | 50.90M | 38.11M | 34.94M | 20.47M | 15.49M | 14.02M | 13.46M | 13.46M | 9.72M | 9.71M | 9.50M | 8.75M |
Weighted Avg Shares Out (Dil) | 117.20M | 138.96M | 69.54M | 50.90M | 38.11M | 34.94M | 20.47M | 15.49M | 14.02M | 13.46M | 13.46M | 9.72M | 9.71M | 9.50M | 8.75M |
MDWerks' Two Trees Beverage Subsidiary Unveils Tim Smith's Climax Honey Raspberry Flavored Whiskey™
MDWerks' Two Trees Beverage Subsidiary Partners with Green Glass Global to Augment Sales Initiatives
Cannabis Stocks Plummet By Up To 16% On DEA Rescheduling Delay: Could This Be The Buying Opportunity Of 2024?
Verizon: The Market Is Missing The Forest For The Trees
Artelo Biosciences Presents Highly Encouraging Data Towards Developing a Solid Dosage Form of ART12.11 at CT-CANN24
Cannabis Stocks Under $2: Why Are These Small-Cap Shares Up While Broader Sector Is In The Red?
From Miles Above, Satellite Data Helps Spot Hazardous Trees and Reduce Wildfire Risk
Money Trees: 3 Top Stocks to Buy for $5,000 in Annual Dividend Income
TREES Corporation Announces Strategic Restructuring of Senior Secured Loan; Resets 2024 for Growth Focusing on Revenue & Cash Flow Initiatives
Trees Corporation looks elsewhere as 420 Investments terminates merger
Source: https://incomestatements.info
Category: Stock Reports